Cargando…
Allosteric inhibition of the epidermal growth factor receptor through disruption of transmembrane interactions
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase (RTK) commonly targeted for inhibition by anticancer therapeutics. Current therapeutics target EGFR’s kinase domain or extracellular region. However, these types of inhibitors are not specific for tumors over healthy tissue an...
Autores principales: | Rybak, Jennifer A., Sahoo, Amita R., Kim, Soyeon, Pyron, Robert J., Pitts, Savannah B., Guleryuz, Saffet, Smith, Adam W., Buck, Matthias, Barrera, Francisco N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362150/ https://www.ncbi.nlm.nih.gov/pubmed/37315787 http://dx.doi.org/10.1016/j.jbc.2023.104914 |
Ejemplares similares
-
Design and development of stapled transmembrane peptides that disrupt the activity of G-protein–coupled receptor oligomers
por: Botta, Joaquín, et al.
Publicado: (2019) -
Topological Analysis of Hedgehog Acyltransferase, a Multipalmitoylated Transmembrane Protein
por: Konitsiotis, Antonio D., et al.
Publicado: (2015) -
Hydrophobic Mismatch Drives the Interaction of E5 with the Transmembrane Segment of PDGF Receptor
por: Windisch, Dirk, et al.
Publicado: (2015) -
Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein
por: Loo, Tip W., et al.
Publicado: (2015) -
Two Conserved Residues Are Important for Inducing Highly Ordered Membrane Domains by the Transmembrane Domain of Influenza Hemagglutinin
por: Ge, Mingtao, et al.
Publicado: (2011)